Zacharias Wijfjes

6PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Supramolecular chemistryInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 08, 2025
Galectin-9 binding to HLA-DR in dendritic cells controls immune synapse formation and T cell proliferation.

Andrea Rodgers-Furones, Thijs Brands, Guusje van Gameren

|May 09, 2025
Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responses.

Zacharias Wijfjes, Iván Ramos Tomillero, Camille M Le Gall

|Apr 09, 2025
Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Angela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall

|Sep 18, 2023
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors.

Zacharias Wijfjes, Floris J van Dalen, Camille M Le Gall

|Aug 12, 2022
Regulatory T Cell Depletion Using a CRISPR Fc-Optimized CD25 Antibody.

Marit J van Elsas, Johan M S van der Schoot, Alexander Bartels

|Apr 16, 2022
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion.

Camille Le Gall, Anna Cammarata, Lukas de Haas

Pageof 1

Frequent Collaborators

5 joint publications

Martijn Verdoes

3 joint publications

Camille M Le Gall

3 joint publications

Ferenc A Scheeren

2 joint publications

Carl G Figdor